Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Iterum Therapeutics plc logo

Iterum Therapeutics plc

Sector: Healthcare   

Industry: Biotechnology

1.48
 
USD
  
-0.02
  
(-1.33%)
Optionable: No  Market Cap: 19 M  90-day average vol: 623,547

Previous close: 1.5  Open: 1.49  Bid: 1.46  Ask: 1.52
52 week range    
0.62   
   2.50
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Tuesday 20th February 2024
31
MarketXLS Rank
40
Value
23
Technical
31
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ITRM Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-132.3-106.5-32.55-8.4
Basic EPS total-132.3-106.5-32.55-8.4-3.63
Basic weighted shares outstanding582273.0967869.02 M11 M12 M
Depreciation-136000.0152000.0161000.0391000.0-84000.0
DepreciationAndAmortization-136000.0152000.0161000.0391000.0-84000.0
Diluted EPS total-132.3-106.5-32.55-8.4-3.63
Diluted weighted shares outstanding582273.0967869.02 M11 M12 M
GainOnSaleOfSecurity-2 M-61 M5 M
GeneralAndAdministrativeExpense9 M11 M11 M14 M13 M
Gross operating profit869000.037000.0
Income before tax-77 M-103 M-51 M-91 M-44 M
Income taxes472000.0444000.0743000.0705000.0301000.0
Interest income-426000.0-861000.0-15 M-6 M-20 M
MiscOtherSpecialCharges401000.0196000.0-2 M195000.0503000.0
Net income from total operations-77 M-103 M-52 M-92 M-45 M
NetIncomeCommonStockholders-77 M-103 M-52 M-92 M-45 M
NetIncomeContinuousOperations-77 M-103 M-52 M-92 M-45 M
NetNonOperatingInterestIncomeExpense-426000.0-861000.0-15 M-6 M-20 M
Normalized income-72 M
Operating income-77 M-102 M-32 M-25 M-30 M
Operating income before depreciation (EBITDA)-76 M-102 M-40 M-84 M-40 M
OperatingExpense77 M102 M32 M25 M-30 M
Other income net-401000.0-196000.04 M61 M-6 M
OtherGandA9 M11 M11 M14 M13 M
OtherOperatingExpenses-77 M-2 M-563000.025 M-30 M
RentAndLandingFees13 M
Research & development expense69 M91 M21 M11 M18 M
ResearchExpense69 M91 M21 M11 M18 M
Revenue per share-360000.0362000.011 M4 M-2 M
Selling Gen & administrative expense9 M11 M11 M14 M13 M
Total Income available for interest expense (EBIT)-77 M-103 M-51 M-91 M-44 M
Total common shares outstanding957829.0991264.012 M12 M13 M
Total net income-77 M-103 M-52 M-92 M-45 M
Total ordinary shares13 M13 M13 M13 M13 M
Total revenues869000.037000.0
TotalExpenses77 M102 M32 M25 M-30 M
TotalRevenue869000.037000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University